Cognate Insights

[null]

Media Inquiries

Cognate’s team is available to discuss our recent news further.

Contact

Charles River Laboratories Completes the Acquisition of Cognate BioServices

WILMINGTON, Mass.--(BUSINESS WIRE)--Mar. 29, 2021-- Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously... Read More

Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe

Cognate BioServices, Inc., the premier commercial-ready, global CDMO in the Cell and Gene Therapy industry, announced today its plans to expand cell and gene therapy... Read More

Cognate BioServices, the Leading Biologics CDMO, Selects L7 Informatics to Implement L7|ESP for Integrated Manufacturing and Lab Operations

L7 Informatics announced that it has partnered with Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, to deploy L7|ESP... Read More

Cognate BioServices Names Tom Pamukcoglu as VP, Global Head of Quality

MEMPHIS, Tennessee, November 2, 2020 /PRNewswire/ -- Cognate BioServices, Inc., the premier commercial-ready CDMO in the Cell & Gene Therapy industry, announced today the... Read More

J. Kelly Ganjei to speak at the Morgan Stanley Global Healthcare Conference

Join Cognate's CEO, J. Kelly Ganjei, as he speaks at the upcoming Morgan Stanley Global Healthcare Conference - Thursday, September 17 at 2:45pm EDT.  ... Read More

J. Kelly Ganjei of Cognate announced as an Entrepreneur Of The Year® 2020 Southeast Award Finalist

Ernst & Young LLP (EY US) today announced that J. Kelly Ganjei, CEO of Cognate BioServices, Inc. was named an Entrepreneur Of The Year® 2020 Southeast Award finalist. Now in... Read More

Cognate Reveals New Brand Identity with Redesigned Logo and Website

  Read More

Join Cognate BioServices at the CAR-TCR Summit in Boston

September 14-17, 2020 Boston, MA Read More
No More Posts